We identified high levels of GABA and its role in enhancing brain metastasis in NSCLC, elucidating the underlying mechanism involving the FOXA2/ABAT/GABA-dependent metabolic pathway. The gene discussed is FOXA2; the disease is non-small cell lung carcinoma.